These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16422308)

  • 61. Cluster randomized controlled trials in primary care: an introduction.
    Murphy AW; Esterman A; Pilotto LS
    Eur J Gen Pract; 2006; 12(2):70-3. PubMed ID: 16945880
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Group sequential testing for cluster randomized trials with time-to-event endpoint.
    Li J; Jung SH
    Biometrics; 2022 Dec; 78(4):1353-1364. PubMed ID: 34076257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Meta-analyses of cluster randomization trials. Power considerations.
    Donner A; Piaggio G; Villar J
    Eval Health Prof; 2003 Sep; 26(3):340-51. PubMed ID: 12971203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A powerful and robust test statistic for randomization inference in group-randomized trials with matched pairs of groups.
    Zhang K; Traskin M; Small DS
    Biometrics; 2012 Mar; 68(1):75-84. PubMed ID: 21732926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cluster randomization trials in tropical medicine: a case study.
    Klar N; Gyorkos T; Donner A
    Trans R Soc Trop Med Hyg; 1995; 89(4):454-9. PubMed ID: 7570898
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Statistical principles for clinical trials.
    Kay R
    J Int Med Res; 1998; 26(2):57-65. PubMed ID: 9602983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sequential monitoring of covariate adaptive randomized clinical trials with sample size re-estimation.
    Yu J; Lai D
    Contemp Clin Trials; 2019 Dec; 87():105874. PubMed ID: 31678412
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A unified method for monitoring and analysing controlled trials.
    Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis.
    Cosby RH; Howard M; Kaczorowski J; Willan AR; Sellors JW
    Fam Pract; 2003 Feb; 20(1):77-82. PubMed ID: 12509376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Confidence interval estimation for treatment effects in cluster randomization trials based on ranks.
    Zou G
    Stat Med; 2021 Jun; 40(14):3227-3250. PubMed ID: 33942338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.
    Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V
    J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interim analyses and stopping rules in cancer clinical trials.
    Whitehead J
    Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Block randomization in clinical trials].
    Yang HL; Wu XB; Mao C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Apr; 53(4):437-440. PubMed ID: 30982284
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The use of group sequential designs with common competing risks tests.
    Logan BR; Zhang MJ
    Stat Med; 2013 Mar; 32(6):899-913. PubMed ID: 22945865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative evaluation of balancing properties of stratified randomization procedures.
    Kundt G
    Methods Inf Med; 2009; 48(2):129-34. PubMed ID: 19283309
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials.
    Wu S; Crespi CM; Wong WK
    Contemp Clin Trials; 2012 Sep; 33(5):869-80. PubMed ID: 22627076
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of the equivalence approach in reproductive health clinical trials.
    Piaggio G; Pinol AP
    Stat Med; 2001 Dec; 20(23):3571-7. PubMed ID: 11746338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.